Baxter Highlights New Home Dialysis and HDx Therapy Data in
Controlled study at 21 hospitals shows remote patient management reduces adverse events for home peritoneal dialysis patientsNew ex vivo study demonstrates...
Stay updated with breaking news from Middle Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Controlled study at 21 hospitals shows remote patient management reduces adverse events for home peritoneal dialysis patientsNew ex vivo study demonstrates...
Credit: MIDL Professor Yutaka Akiyama of the School of Computing, Professor Kohji Seio of the School of Life Science and Technology, and others at Tokyo Institute of Technology (Tokyo Tech) have established Fastide, Inc. (Representative: Shinichiro Fujiie, Kawasaki City) as part of their aim to bring their research results on middle molecule drug discovery [Note 1] to society. Tokyo Tech and Fastide, Inc. are cooperating with Kawasaki City through the Program for Building Regional Innovation Ecosystems to promote integrated research of AI drug discovery and chemical synthesis technologies and...